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Abstract 
Background: Detection of paroxysmal atrial fibrillation (PAF) in acute ischemic stroke pa-
tients poses diagnostic challenge. The aim of this study was to predict the presence of PAF by 
means of 12-lead ECG in patients with acute ischemic stroke. Our hypothesis was that P-wave 
dispersion (Pd) might be a useful marker in predicting PAF in patients with acute ischemic 
stroke.  
Methods: 12-lead resting ECGs, 24-hour Holter recordings and echocardiograms of 400 
patients were analyzed retrospectively. PAF was detected in 40 patients on 24-hour Holter 
monitoring. Forty out of 360 age and gender matched patients without PAF were randomly 
chosen and assigned as the control group. Demographics, P-wave characteristics and echo-
cardiographic findings of the patients with and without PAF were compared. 
Results:  Maximum  P-wave  duration  (p=0.002),  Pd  (p<0.001)  and  left  atrium  diameter 
(p=0.04) were significantly higher in patients with PAF when compared to patients without 
PAF. However, in binary logistic regression analysis Pd was the only independent predictor of 
PAF. The cut-off value of Pd for the detection of PAF was 57.5 milliseconds (msc). Area under 
the curve was 0.80 (p<0.001). On a single 12-lead ECG, a value higher than 57.5 msc predicted 
the presence of PAF with a sensitivity of 80% and a specificity of 73%. 
Conclusion: Pd on a single 12-lead ECG obtained within 24 hours of an acute ischemic stroke 
might help to predict PAF and reduce the risk of recurrent strokes. 
Key words: P-wave dispersion, acute ischemic stroke, 12-lead ECG, paroxysmal atrial fibrillation, 
24- hour Holter monitoring. 
Introduction 
Atrial fibrillation (AF) is a common cardiac ar-
rhythmia  and  constitutes  the  etiology  in  almost 
15-20% of all ischemic strokes [1]. However when AF 
is paroxysmal a detailed investigation is warranted. 
Guidelines  recommend  at  least  24-hour  inpatient 
Holter monitoring in ischemic stroke patients albeit 
recent studies suggest that more prolonged monitor-
ing might be essential to increase the chance of de-
tecting PAF [1-3].  
In previous studies, echocardiographic left atrial 
diameter (LAD) and premature atrial contractions on 
Holter monitoring were the predictors of PAF in pa-
tients with acute ischemic stroke [4, 5]. But because of 
high  costs  and  technical  inconvenience,  standard 
12-lead  ECG  is  still  the  most  commonly  used  tech-
nique  [6].  P-wave  dispersion  (Pd)  measured  from  a 
single  ECG  is  regarded  as  an  electrocardiographic 
marker of inhomogeneous and discontinuous propa-
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gation  of  sinus  impulses  [7,  8].  To  the  best  of  our 
knowledge, Pd has not been investigated in patients 
with acute ischemic stroke in whom the risk of a re-
current  disabling  or  mortal  stroke  is  substantially 
high. We aimed to determine the predictive value of 
Pd in this particular patient population.  
Methods 
This retrospective study was conducted in Car-
diology and Neurology Departments of Selcuk Uni-
versity, Meram School of Medicine with the approval 
of the Institutional Ethics Committee.  
Patient population 
Twenty-four hour Holter records of 400 patients 
investigated for an acute ischemic stroke in neurology 
department were reviewed. Patients evaluated by a 
cardiologist  and  underwent  standard  12-lead  ECG 
recording within the first 24 hours of stroke and those 
were further evaluated with 24-hour Holter record-
ings (Pathfinder Digital Holter Analyzer and Lifecard 
CF  Holter  Recorders,  Reynolds  Medical,  Hertford, 
UK)  and  echocardiography  (Philips,  Envisor  C, 
Bothell, WA, USA) during the hospitalization period 
were eligible for the study. The decision of monitoring 
a patient with 24-hour Holter was based on the pref-
erence  of  attending  cardiologist.  All  of  the  Holter 
monitorizations  and  echocardiograms  were  con-
ducted  within  2  to  7  days  of  admission.  Acute  is-
chemic stroke diagnosis was made by a neurologist. 
Acute ischemic stroke was defined as persistent neu-
rologic deficits lasting longer than 24 hours and in-
farct on cranial MRI. PAF was considered when nor-
mal  sinus  rhythm  was  replaced  by  irregular  tachy-
cardia lasting more than 30 seconds with no visible 
P-wave  or  with  unorganized  F  wavelets  of  AF  on 
24-hour Holter recording. Frequent atrial premature 
complexes  (APCs)  were  defined  as  presence  of  ≥70 
APCs  per  24  hours  [9].  Among  400  Holter  records 
reviewed, PAF was diagnosed in 40 patients. Then, 
among  remaining  360  patients  without  PAF  on 
24-hour Holter monitoring, another 40 subjects were 
randomly matched for age and gender and assigned 
as the control group. 
Patients  with  evidence  of  hemorrhagic  stroke, 
subarachnoid hemorrhage, recent myocardial infarc-
tion  (<40  days),  severe  left  ventricular  systolic  dys-
function  (EF  <  30%),  decompensated  heart  failure, 
ventricular aneurysm, intracardiac thrombus or any 
other  cause  of  cardiac  embolism  detected  by  trans-
thoracic  echocardiography  were  excluded  from  the 
study. Other exclusion criteria were previously doc-
umented  AF,  having  rhythm  other  than  sinus,  ob-
structive sleep apnea, electrolyte disturbance, thyroid 
and pulmonary disease. The patients with transient 
ischemic attack were not included in the study, since 
accurate diagnosis of this entity consists of two chal-
lenging steps –documentation of the brief episode of 
neurological  dysfunction  and  exclusion  of  acute  in-
farction by neuroimaging. As endorsed by the scien-
tific statement from American Heart Association and 
American Stroke Association, TIA is now regarded as 
“a brief episode of neurological dysfunction caused 
by focal brain or retinal ischemia, with clinical symp-
toms typically lasting less than one hour, and without 
evidence of acute infarction” [10]. Hence, we preferred 
to include only infarcts in which of all the diagnosis 
was confirmed by means of neurological examination 
findings and magnetic resonance imaging. 
Analyses of ECG and echocardiographic pa-
rameters 
Twelve-lead resting ECGs which were obtained 
in  the  first  24  hours  of  admission  to  the  neurology 
department  for  an  acute  ischemic  stroke  were  re-
viewed and analysed. All ECGs were recorded at a 
paper speed of 25 mm/s and a calibration of 1mV = 10 
mm  (Cardioline  Delta  60  Plus,  Remco  SpA,  Milan, 
Italy). To prevent the influence of circadian parame-
ters  on  P-wave  parameters,  ECGs  which  were  ob-
tained in the morning hours (between 08.00 and 12.00) 
were  analysed.  One  of  the  participant  cardiologists 
(M.A.) who was blinded to clinical and Holter data 
made  all  the  ECG  analysis  by  using  a  magnifying 
glass.  
Three consecutive beats were used for analysis 
and  at  least  10  leads  were  analyzable  in  all  ECGs. 
P-wave duration was defined as the time measured 
from the onset to the end of the P-wave deflection. 
The onset of the P-wave was considered as the junc-
tion between isoelectric line and first visible upward 
or  downward  slope  of  the  trace.  The  return  of  the 
trace to the isoelectric line was considered to be the 
end of the P-wave. Pd was defined as the difference 
between maximum and minimum P-wave durations 
(Pmax and Pmin, respectively) occurring in any of the 12 
leads [7].  
Intraobserver  variability  of  manual  Pd  meas-
urements was tested in 30 randomly selected patients. 
Agreement between Pd  measurements was assessed 
using the Bland-Altman method [11]. The 95% limits 
of agreement for Pd were -11.7 and 13.7 milliseconds 
(msc), which means that there was a 95% probability 
that  the  repeated  measurements  differed  no  more 
than -11.7 to 13.7 msc from the first measurement. The 
95% limits of agreement for Pmax were -10.6 and 11.2 
msc.  Furthermore,  electrocardiograms  of  the  same 
patient group were scanned at 300 dpi and P-wave Int. J. Med. Sci. 2012, 9 
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parameters  were  measured  by  another  cardiologist 
(U.D.) on a high resolution computer screen. When 
manual  and  digital  measurements  were  compared, 
the 95% limits of agreement for Pd were -11.1 and 12.4 
msc, and for Pmax were -12.1 and 13.5 msc, respectively 
(Figure 1). 
Routine echocardiographic parameters including 
left ventricular ejection fraction (LV EF), left ventric-
ular end-diastolic diameter (LVEDD), left ventricular 
end-systolic  diameter  (LVESD)  and  LAD  were  also 
recorded.  Thereafter,  demographics  and  P-wave 
characteristics of the patients with and without PAF 
were compared.  
Statistical analyses 
Continuous variables were expressed as mean ± 
standard deviation and categorical variables as num-
bers.  Significances  of  the  differences  between  the 
groups  were  tested  by  the  two-sided  independent 
samples t-test. Pearson’s chi-square test was used for 
categorical  comparisons  of  nominal  values.  Simple 
relations  between  Pmax,  Pd,  age,  heart  rate,  LV  EF, 
LVEDD  and  LAD  were  assessed  by  using  Pearson 
correlation. A binary logistic regression analysis was 
performed  to  identify  the  predictors  of  presence  of 
PAF during 24-hour Holter monitoring. Receiver op-
erating characteristic (ROC) curves were generated to 
identify the optimal cut-off values of Pd to predict the 
presence of PAF on 24-hour Holter monitoring. The 
validity of the model was measured by means of the 
area under ROC curve. A p value less than 0.05 was 
considered  to  be  statistically  significant.  Data  were 
analyzed  by  using  SPSS  for  Windows  version  15.0 
(SPSS Inc., Chicago, IL, USA).  
Results 
The  groups  of  acute  ischemic  stroke  patients 
with and without PAF in 24-hour Holter monitoring 
were well matched with regard to hypertension, dia-
betes mellitus, hyperlipidemia and being on medica-
tions  including  statins,  angiotensin-converting  en-
zyme inhibitors, angiotensin receptor, calcium chan-
nel and beta blockers. Besides, there were no signifi-
cant  differences  between  the  groups  regarding 
smoking, coronary artery disease, previous myocar-
dial  infarction,  pre-existing  systolic  heart  failure, 
valvular heart disease and recurrent stroke (Table 1). 
Heart rate, creatinine, blood urea nitrogen, total cho-
lesterol, LDL-cholesterol and hemoglobin levels, LV 
end-diastolic and -systolic diameters and left ventric-
ular ejection fraction were also similar. Proportion of 
patients with frequent APCs did not differ between 
the groups.  
Maximum  P-wave  duration  (p=0.002),  Pd 
(p<0.001) and left atrium diameter (p=0.04) were sig-
nificantly  higher  in  patients  with  PAF  when  com-
pared  to  those  without  PAF  (Table  1).  Correlation 
analyses between Pmax, Pd and age, heart rate, LV EF, 
LVEDD and LAD were performed (Table 2). A sig-
nificant positive correlation was determined between 
Pd and LAD (β=0.36, p=0.01) and between Pmax and 
LAD (β=0.36, p=0.01).  
 
 
Figure 1. Bland-Altman plots demonstrating the 95% limits of agreement between (A) the repeated measurements of Pd by the same 
observer and (B) between the manual and digital measurements of Pd by different observers, in 30 randomly selected patients. Abbre-
viations: msc: millisecond; SD: standard deviation. 
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Table 1. Comparison of demographic characteristics, 
medications on admission
*, echocardiographic indices, Pmax, 
Pmin and Pd of the patients with and without paroxysmal 
atrial fibrillation. 
Parameter  Patients with 
PAF  
(n=40) 
Patients with-
out PAF (n=40) 
p value 
Age  69±12  69±13   0.78 
Gender(male/female)  26/14  26/14   1 
Hypertension  20 (50%)  22 (55%)   0.65 
Diabetes mellitus  14 (35%)  12 (30%)   0.63 
Hyperlipidemia   5 (12.5%)  7 (17.5%)   0.53 
Smoking  10 (25%)  12 (30%)   0.62 
Coronary artery dis-
ease 
6 (15%)  7 (17.5%)   0.76 
Previous MI  3 (7.5%)  2 (5%)   0.64 
Pre-existing systolic 
HF 
4 (10%)  3 (7.5%)   0.69 
Valvular heart dis-
ease 
1 (2.5%)  0 (0%)   0.31 
Recurrent stroke  4 (10%)  5 (12.5%)   0.72 
Beta blocker  5 (12.5%)  4 (10%)   0.72 
Ca blocker  8(20%)  7 (17.5%)   0.78 
ACEI/ARB  11 (27.5%)  9 (22.5%)   0.61 
Statin  5 (12.5%)  6 (15%)   0.75 
LAD (mm)  38±6  36±5   0.04 
LV EF (%)  58±7  59±7   0.62 
LVEDD (mm)  46±6  46±6   0.83 
LVESD (mm)  27±5  28±6   0.31 
Heart rate (bpm)   73±11  72±10   0.68 
Frequent APCs  13 (32.5%)  11 (27.5%)   0.63 
Pmax (msc)  115±18  103±13   0.002 
Pmin (msc)  50±13  53±12   0.23 
Pd (msc)  65±14  50±12   <0.001 
*Drugs which might affect the atrial conduction properties.  
Abbreviations: ACEI: angiotensin converting enzyme inhibitor; ARB: angio-
tensin receptor blocker; HF: heart failure; LAD: left atrial diameter; LV EF: 
left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diam-
eter; LVESD: left ventricular end-systolic diameter; MI: myocardial infarction; 
msc: millisecond; PAF: paroxysmal atrial fibrillation; Pmax: maximum P-wave 
duration; Pmin: minimum P-wave duration; Pd = P-wave dispersion. 
 
 
Table 2. Correlations of Pd and Pmax with age, heart rate, LV 
EF, LVEDD and LAD in the whole patient population. 
  Age  Heart 
rate 
 LV EF   LVEDD   LAD   Pmax   Pd 
Pmax  -0.05   -0.09    -0.08   0.21   0.36*    -  0.69** 
Pd  -0.02    0.02   0.07    0.13    0.36*   0.69**   - 
Abbreviations: LAD: left atrial diameter; LV EF: left ventricular ejection 
fraction; LVEDD: left ventricular end-diastolic diameter; Pmax: maximum 
P-wave duration; Pd: P-wave dispersion. *p < 0.05, **p < 0.01. 
 
 
In binary logistic regression analysis, Pd was the 
only independent predictor of PAF in acute ischemic 
stroke patients (Table 3). The optimum cut-off value 
for Pd determined by ROC curve was 57.5 msc. On a 
single 12-lead ECG, a Pd value higher than 57.5 msc 
predicted  presence  of  PAF  with  sensitivity  of  80%, 
specificity  of  73%,  positive  predictive  value  of  74% 
and negative predictive value of 78%. The area under 
curve was 0.80 (p<0.001, 95% CI: 0.70-0.90) (Figure 2). 
Table 3. Logistic regression analysis shows that detection 
of PAF on 24-hour Holter monitoring increased by odds 
ratio of 2.7 for each 10 msc Pd increment. 
  Odds ratio  95% CI   Sig. 
Hypertension   0.80  0.25-2.64  0.72 
Diabetes mellitus  1.20  0.36-4.02  0.77 
Hyperlipidemia  0.83  0.17-4.19  0.82 
Smoking  1.44  0.35-5.85  0.62 
Coronary artery dis-
ease  
0.35  0.06-2.14  0.25 
Pmax*  1.11  0.68-1.83  0.68 
Pd*  2.74  1.48-5.07  0.001 
LV EF (%)  0.91  0.82-1.01  0.07 
LVEDD (mm)  0.44  0.11-1.70  0.23 
LAD (mm)  2.36  0.64-8.68  0.20 
* Odds ratio per 10 msc change. 
Abbreviations: LAD: left atrial diameter; LV EF: left ventricular ejection 
fraction; LVEDD: left ventricular end-diastolic diameter; msc: millisecond; 
Pmax: maximum P-wave duration; Pd: P-wave dispersion. 
 
 
Figure  2.  Receiver  operator  characteristic  (ROC)  curve 
demonstrating sensitivity as a function of 1-specifity for predicting 
presence of PAF in 24-hour ECG-Holter monitoring based on the 
logistic model incorporating relative contributions of Pd and Pmax. 
The area under the ROC curve were 0.80 (p<0.001) and 0.70 
(p=0.001), respectively. Abbreviations: Pd: P-wave dispersion; Pmax: 
maximum P-wave duration.  Int. J. Med. Sci. 2012, 9 
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Discussion 
As far as we know, this is the first study demon-
strating an association between Pd and PAF in patients 
with acute ischemic stroke. Pd is a simple index and 
can be easily measured by a 12-lead ECG. This might 
be a useful tool to predict the presence of PAF in pa-
tients with acute ischemic stroke with a sinus rhythm 
at the time of presentation. 
Despite  advances  in  diagnostic  and  interven-
tional procedures, cardiac causes constitute the etiol-
ogy  in  a  high  proportion  of  patients  with  ischemic 
stroke [12]. The association between PAF and stroke 
has  been  shown  to  be  considerably  strong  [13].  Is-
chemic  stroke  patients  -either  with  paroxysmal  or 
permanent AF- have greater mortality and morbidity 
rates when compared to those without AF [1]. On the 
other  hand,  poor  outcome  associated  with  PAF  is 
preventable  with  anticoagulation  in  nearly  40%  of 
patients and it is clinically crucial to detect these pa-
tients  [14].  However,  unlike  permanent  AF,  PAF 
might  not  be  diagnosed  readily  and  can  be  easily 
overlooked. Clinical guidelines recommend that pa-
tients with acute ischemic stroke should be evaluated 
with 24-hour inpatient monitoring to detect PAF [2]. 
But,  24-hour  Holter  monitoring  might  have  a  low 
yield diagnosing only 2.4% - 9.4% of these patients [3, 
15,  16].  Possibility  of  detecting  PAF  with  24-hour 
Holter  monitoring  might  be  even  lower  (1-5%). 
Moreover, it has recently been reported that there was 
no significant difference between Holter monitoring 
and serial ECG assessment in AF detection in patients 
with stroke/transient ischemic attacks [17]. Similar to 
these  data,  Shafqat  et  al.  have  reported  that  Holter 
monitoring did not always detect AF in patients who 
were  AF-positive  on  ECG  [15].  These  findings  give 
support  to  the  studies  which  suggest  that  Holter 
monitoring  might  have  the  potential  of  underesti-
mating AF in ischemic stroke patients [6, 18].  
The challenges mentioned above have led to in-
vestigations in this area. Pd is one of the most investi-
gated parameters. Pd assessed on a single resting ECG 
is  regarded  as  a  noninvasive  electrocardiographic 
marker which reflects the prolongation of intraatrial 
and interatrial conduction time in addition to discon-
tinuous propagation of sinus impulses [7]. It has been 
demonstrated that prolongation of Pd is a risk factor 
for  the  development  of  PAF  independent  from  the 
presence of structural heart diseases. It also has been 
shown that Pd might predict transition from PAF to 
permanent AF [7, 19].  
In our study Pd was the only independent pre-
dictor  of  PAF  in  acute  ischemic  stroke  patients.  In 
logistic  regression  analysis,  detection  of  PAF  on 
24-hour Holter monitoring increased by odds ratio of 
2.7 for each 10 msc Pd increment. In ROC curve anal-
ysis Pd alone with a cut-off value of 57.5 msc had a 
sensitivity of 80% and a specificity of 73% to predict 
presence  of  PAF  which  was  detected  on  24-hour 
Holter monitoring. 95% CI of area under the curve of 
Pd (0.70-0.90) did not include 0.5, therefore we con-
sidered that these predictive values were reliable [20]. 
Normal  values  of  Pd  have  ranged  from  28  to  52 
mseconds  in  the  literature  [21,  22].  In  their  study 
evaluating 502 adults without evident cardiovascular 
disease (30.3% hypertensive, 12.2% diabetic) Magnani 
et al. reported mean Pd value as 48±12 msc [23]. Alt-
hough, mean Pd values of our study population are 
comparable to several studies mentioned above, they 
are  higher  than  the  average  in  the  literature.  This 
might be explained by the characteristics of our study 
population. Both PAF and control groups consisted of 
acute ischemic stroke patients with high proportions 
of risk factors for increased Pd such as hypertension 
and diabetes mellitus [24, 25]. 
We also found that P-wave duration (Pmax) was 
significantly longer in patients with PAF when com-
pared to patients without PAF (p=0.002). This finding 
is consistent with previously published data in which 
significantly longer intraatrial and interatrial conduc-
tion  time  of  impulses  associated  with  P  wave  pro-
longation  in  12-lead  ECG  recordings  have  been 
demonstrated in individuals with a clinical history of 
PAF [7]. However, in our study, although, Pmax had a 
good correlation with Pd (β=0.69, p<0.001), it was not 
an independent risk factor for presence of PAF. Re-
cent literature suggests that both Pmax and Pd might be 
the  predictors  of  arrhythmogenesis  and  nonsudden 
cardiac death [26]. Albeit prolonged Pmax and Pd, either 
separately or together, have been shown to be associ-
ated  with  increased  incidence  of  AF  in  diverse  cir-
cumstances, which one is superior to the other as a 
predictive risk factor remains unclear and needs to be 
established  in  large-scaled  prospectively  designed 
studies.  
Bland-Altman  analysis  demonstrated  that  both 
intraobserver  variability  of  repeated  manual  meas-
urements and agreement between manual and digital 
measurements were within clinically acceptable lim-
its. These results suggest that Pd may be considered as 
a reliable, inexpensive tool as a first-line diagnostic 
test which can alert the physician for further investi-
gation  of  presence  of  PAF  in  acute  ischemic  stroke 
patients.  
Consistent with previous data, there was a posi-
tive correlation between Pd and LAD which in turn 
might be associated with stroke due to an increased 
risk for thrombus formation [27]. However, associa-Int. J. Med. Sci. 2012, 9 
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tion of Pd and PAF was found to be independent from 
LAD,  since  both  parameters  were  put  into  logistic 
regression analysis.  
Study limitations 
Since  24-hour  Holter  monitoring  might  have  a 
low diagnostic yield, a selection bias could have po-
tentially influenced our results. However, it must be 
emphasized that, patients in which PAF is detected on 
24-hour Holter monitoring still constitute a significant 
subgroup  who  are  anticoagulated  for  secondary 
stroke prevention. Also, in clinical practice anticoag-
ulant therapy is not initiated in a considerable number 
of  patients  as  a  consequence  of  absence  of  PAF  on 
24-hour Holter monitoring. Furthermore, this was a 
retrospective  study  and  the  decision  to  detect  ar-
rhythmia  and  to  perform  Holter-monitoring  was 
based on the preference of the attending cardiologist. 
Data of patients who did not undergo Holter moni-
toring were lacking. Hence, relevance of these find-
ings  into  clinical  practice  needs  to  be  verified  with 
randomized prospective studies.  
Body mass index and presence of left ventricular 
hypertrophy are important predictors of AF [28, 29]. 
Additionally, left atrial volume index is reported to be 
superior  to  conventional  M-mode  left  atrial  dimen-
sion in predicting AF [30]. However, these parameters 
were left out due to lack of available data in medical 
reports of the patients.  
Preexisting systolic heart failure was present in 
8.8% (n=7) of all study population whereas 6.3% (n=5) 
had  previous  myocardial  infarction.  In  their  study 
evaluating the outcomes of pre-existing heart failure 
in  acute  ischemic  stroke  patients,  Sharma  et  al.  re-
ported the prevalence of heart failure as 17% [31]. In 
our study, the exclusion of patients with recent myo-
cardial  infarction  (<40  days),  severe  left  ventricular 
systolic dysfunction (EF<30%), ventricular aneurysm, 
intracardiac thrombus or any other cause of cardiac 
embolism  detected  by  transthoracic  echocardiog-
raphy  might  have  led  to  lower  proportions  of 
pre-existing  heart  failure.  Moreover,  influences  of 
seasonal  and  metabolic  factors  such  as  abnormal 
thyroid  hormone  levels  were  potential  confounders 
which could not be excluded from the study. 
Premature  atrial  beats  are  reported  to  be  a 
marker for PAF in patients with acute ischemic stroke 
[9]. However, they were similar in both of the study 
groups. This result may be explained with the small 
sample  size.  Morphologic  characteristics  of  P-wave 
such as the presence of electrocardiographic left atrial 
abnormality –which have been suggested as potential 
risk factors for predicting AF- could have been evalu-
ated in addition to Pd, but were disregarded due to 
small sample size [32].  
Conclusion 
P-wave dispersion as assessed on a single 12-lead 
ECG might guide the physician to predict PAF in this 
high-risk patient population and help to reduce the 
risk of recurrent stroke. Due to mentioned limitations, 
values concerning the sensitivity and specificity must 
be interpreted as an attribution to the potential clinical 
utilization of these parameters, instead of exact values 
showing diagnostic accuracy. Studies based on longer 
monitorization  of  heart  rhythm  by  external  or  im-
plantable loop recorder devices would be beneficial to 
demonstrate definite value of P-wave parameters for 
predicting PAF in patients with acute ischemic stroke.  
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